9-Oct-2026
Globe Newswire (Fri, 9-Oct 7:00 AM ET)
These materials stocks carry A+ EPS revision grades ahead of Q3 results
Seeking Alpha News (Thu, 8-Oct 8:12 AM ET)
Globe Newswire (Wed, 9-Sep 7:00 AM ET)
Balchem Corporation Reports Second Quarter 2026 Financial Results
Globe Newswire (Fri, 31-Jul 7:00 AM ET)
Globe Newswire (Fri, 17-Jul 7:00 AM ET)
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
Balchem trades on the NASDAQ stock market under the symbol BCPC.
As of October 9, 2026, BCPC stock price declined to $167.83 with 154,289 million shares trading.
BCPC has a beta of 0.30, meaning it tends to be less sensitive to market movements. BCPC has a correlation of 0.03 to the broad based SPY ETF.
BCPC has a market cap of $5.39 billion. This is considered a Mid Cap stock.
Last quarter Balchem reported $284 million in Revenue and $1.49 earnings per share. This beat revenue expectation by $15 million and exceeded earnings estimates by $.07.
In the last 3 years, BCPC traded as high as $186.03 and as low as $110.74.
The top ETF exchange traded funds that BCPC belongs to (by Net Assets): IJR, VTI, IWM, VB, SDVY.
BCPC has outperformed the market in the last year with a return of +18.5%, while the SPY ETF gained +16.8%. However, in the most recent history, BCPC shares have underperformed the stock market with its stock returning +1.1% in the last 3 month period and 0.0% for the last 2 week period, while SPY has returned +4.7% and +1.5%, respectively.
BCPC support price is $166.24 and resistance is $171.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BCPC shares will trade within this expected range on the day.